Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability

Lixin Liu,Dongyu Zou,Yunan Zhang,Qiang Zhang,Yanru Feng,Yingxue Guo,Yingli Liu,Xuesong Zhang,Guangdong Cheng,Chaoxing Wang,Yunjie Zhang,Lei Zhang,Lili Wu,Liang Chang,Xin Su,Yu Duan,Yanfei Zhang,Moqi Liu
DOI: https://doi.org/10.1016/j.ejpb.2020.06.018
IF: 5.589
2020-09-01
European Journal of Pharmaceutics and Biopharmaceutics
Abstract:<p>Base on improving the solubility and permeability of enoxacin (EX) to enhance the antibacterial activity in vitro, three new pharmaceutical salts/cocrystals of EX with oxalic acid (EX·0.5(C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>)·2(H<sub>2</sub>O)), malonic acid ((HEX)·C<sub>3</sub>H<sub>3</sub>O<sub>4</sub>) and fumaric acid ((HEX)·C<sub>4</sub>H<sub>3</sub>O<sub>4</sub>) have been designed, synthesized and characterized. Comprehensive analysis structure and Hirshfeld surface reveal that the hydrogen bonds/CAHBs formed by the N atom in the piperazine ring from EX molecule with the carboxylic acid group in the coformer could form a stable crystal structure. It is universally acknowledged that improving the solubility of the EX (BCS class II) to make it a BCS class I drug would obtain a Bioequivalence of immunity to the drug trial. The solubilities of three pharmaceutical salts/cocrystals of EX with dicarboxylic acids are consistent with expectation that they are dramatically improved in pure water than pure enoxacin, and the solubility order of three pharmaceutical salts/cocrystals of EX is consistent with coformers solubility. The permeabilities of three pharmaceutical salts/cocrystals of EX are improved compared with the pure enoxacin, and the variation tendency is consistent with the solubilities of three pharmaceutical salts/cocrystals of EX. In addition, the antibacterial activities in vitro of three pharmaceutical salts/cocrystals of EX are improved compared with the corresponding parent compound (EX), which change the order is consistent with the solubility and permeability. Simultaneously, the hygroscopic stabilities of three pharmaceutical salts/cocrystals are surpassing pure EX, and the hygroscopic stability of molecular cocrystal EX-OXA is better than ionic cocrystal EX-MLO and EX-FUM. This implies that preparation of the pharmaceutical salts/cocrystals of EX with oxalic acid, malonic acid and fumaric acid could not only enhance the antibacterial activity of EX, which base on improving the solubility and permeability of EX, but also improve the hygroscopic stability of EX.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve The paper aims to enhance the in vitro antibacterial activity of enoxacin (EX) by improving its solubility and permeability. Specifically: 1. **Improving Solubility and Permeability**: - Enoxacin belongs to the Biopharmaceutics Classification System (BCS) Class II drugs, which have high permeability but extremely low solubility. Therefore, the researchers attempted to improve its solubility and permeability by preparing drug salts/cocrystals of enoxacin with dicarboxylic acids (oxalic acid, maleic acid, and fumaric acid). 2. **Enhancing Antibacterial Activity**: - By improving the solubility and permeability of enoxacin, its in vitro antibacterial activity is subsequently enhanced. Experimental results show that the antibacterial activity of the three drug salts/cocrystals is superior to that of pure enoxacin. 3. **Improving Hygroscopic Stability**: - The study also found that the hygroscopic stability of these three drug salts/cocrystals is better than that of pure enoxacin, with the molecular cocrystal EX-OXA exhibiting the best hygroscopic stability. In summary, the main objective of the paper is to improve the solubility, permeability, and antibacterial activity of enoxacin by preparing drug salts/cocrystals with oxalic acid, maleic acid, and fumaric acid, and to enhance its hygroscopic stability.